BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 7662794)

  • 1. [Structure and properties of extracellular proteins regulating the proteolytic phase of complement activation].
    Galebskaia LV; Shcherbak IG; Bel'tiukov PP; Dorofeĭkov VV
    Biokhimiia; 1995 May; 60(5):668-77. PubMed ID: 7662794
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complement and complement regulatory proteins in human tears.
    Willcox MD; Morris CA; Thakur A; Sack RA; Wickson J; Boey W
    Invest Ophthalmol Vis Sci; 1997 Jan; 38(1):1-8. PubMed ID: 9008624
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The complement system].
    Taran LD
    Biokhimiia; 1993 May; 58(5):780-7. PubMed ID: 8338890
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complement protease MASP-1 activates human endothelial cells: PAR4 activation is a link between complement and endothelial function.
    Megyeri M; Makó V; Beinrohr L; Doleschall Z; Prohászka Z; Cervenak L; Závodszky P; Gál P
    J Immunol; 2009 Sep; 183(5):3409-16. PubMed ID: 19667088
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The complement system--structure, activation, regulation and function].
    Bjørge L
    Tidsskr Nor Laegeforen; 1999 Jan; 119(2):226-33. PubMed ID: 10081355
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transcriptional control of genes for soluble complement cascade regulatory proteins.
    Fraczek LA; Martin BK
    Mol Immunol; 2010; 48(1-3):9-13. PubMed ID: 20869772
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The complement system: pathophysiology and clinical relevance.
    Speth C; Würzner R; Stoiber H; Dierich MP
    Wien Klin Wochenschr; 1999 May; 111(10):378-91. PubMed ID: 10413831
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A second serine protease associated with mannan-binding lectin that activates complement.
    Thiel S; Vorup-Jensen T; Stover CM; Schwaeble W; Laursen SB; Poulsen K; Willis AC; Eggleton P; Hansen S; Holmskov U; Reid KB; Jensenius JC
    Nature; 1997 Apr; 386(6624):506-10. PubMed ID: 9087411
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hemolytic uremic syndrome: an example of insufficient complement regulation on self-tissue.
    Atkinson JP; Liszewski MK; Richards A; Kavanagh D; Moulton EA
    Ann N Y Acad Sci; 2005 Nov; 1056():144-52. PubMed ID: 16387683
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Study of complement-mediated anaphylaxis in humans. The role of IgG subclasses (IgG1 and/or IgG4) in the complement-activating capacity of immune complexes.
    Bergamaschini L; Santangelo T; Faricciotti A; Ciavarella N; Mannucci PM; Agostoni A
    J Immunol; 1996 Feb; 156(3):1256-61. PubMed ID: 8558005
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of complement and complement regulators in the removal of apoptotic cells.
    Trouw LA; Blom AM; Gasque P
    Mol Immunol; 2008 Mar; 45(5):1199-207. PubMed ID: 17961651
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ligand-binding renders the 160 kDa Trypanosoma cruzi complement regulatory protein susceptible to proteolytic cleavage.
    Norris KA
    Microb Pathog; 1996 Oct; 21(4):235-48. PubMed ID: 8905613
    [TBL] [Abstract][Full Text] [Related]  

  • 13. On the roles of extracellular matrix remodeling by gelatinase B.
    Opdenakker G
    Verh K Acad Geneeskd Belg; 1997; 59(6):489-514. PubMed ID: 9543820
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Complement in lupus nephritis: the good, the bad, and the unknown.
    Bao L; Quigg RJ
    Semin Nephrol; 2007 Jan; 27(1):69-80. PubMed ID: 17336690
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complement activation cascade and its regulation: relevance for the response of solid tumors to photodynamic therapy.
    Korbelik M; Cecic I
    J Photochem Photobiol B; 2008 Oct; 93(1):53-9. PubMed ID: 18715798
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Substrate specificities of the protease of mouse serum Ra-reactive factor.
    Ogata RT; Low PJ; Kawakami M
    J Immunol; 1995 Mar; 154(5):2351-7. PubMed ID: 7868903
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of the P2 residue of complement 1 inhibitor (Ala443) in determination of target protease specificity: inhibition of complement and contact system proteases.
    Zahedi R; Wisnieski J; Davis AE
    J Immunol; 1997 Jul; 159(2):983-8. PubMed ID: 9218620
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Studies on the interactions between C-reactive protein and complement proteins.
    Bíró A; Rovó Z; Papp D; Cervenak L; Varga L; Füst G; Thielens NM; Arlaud GJ; Prohászka Z
    Immunology; 2007 May; 121(1):40-50. PubMed ID: 17244159
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Complement system--an effector of inflammatory reactions. Possibilities of complement regulation in ischaemic diseases].
    Madaliński K; Cedzyński M; Swierzko A; Szczepańska-Szerej A
    Przegl Epidemiol; 2007; 61(4):701-11. PubMed ID: 18572502
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Guanine nucleotides protect Rho proteins from endogenous proteolytic degradation in renal membranes.
    Desrosiers RR; Gauthier F; Lin W; Béliveau R
    Biochem Cell Biol; 1998; 76(1):63-72. PubMed ID: 9666307
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.